Results 31 to 40 of about 626,236 (265)

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa, Shou Xu, Mark Zobeck, Sarah E. Sartain, Nino Rainusso, Lisa Wang, Nicole Montgomery, Paige Wheaton, Sarah Whittle   +8 more
wiley   +1 more source

Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C

, 2022
Objectives: To evaluate risk factors for postdischarge sequelae in children and adolescents hospitalized for acute coronavirus disease 2019 (COVID-19) or multisystem inflammatory syndrome in children (MIS-C).
Schuster, Jennifer E., FitzGerald, Madyson M., Rowan, Courtney M., Overcoming COVID-19 Investigators, Gertz, Shira J., Berbert, Laura, Irby, Katherine, Schwartz, Stephanie P., Miller, Kristen, Tarquinio, Keiko M., Fitzgerald, Julie C., Crandall, Hillary, Cvijanovich, Natalie Z., Glas Gaspers, Mary, Nofziger, Ryan A., Hume, Janet R., Kucukak, Suden, Young, Cameron C., Shein, Steven L., Feldstein, Leora R., Tenforde, Mark W., Cullimore, Melissa L., Chen, Sabrina R., Randolph, Adrienne G., Maddux, Aline B., Halasa, Natasha B., Levy, Emily R., He, Jie, Weller, Edie, Patel, Manish M., Mack, Elizabeth H., Newhams, Margaret M., Loftis, Laura L., Hobbs, Charlotte V., Zinter, Matt S., Walker, Tracie C., Flori, Heidi, Campbell, Angela P., Kong, Michele, Staat, Mary A., Zambrano, Laura D.   +40 more
core   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro, Freda Qi, Karen Colwill, Alina D. Dorogy, Ying Liu, Michelle Science, Anne‐Claude Gingras, James M. Rini, Sumit Gupta, Sarah Alexander, Shelly Bolotin, Tania H. Watts   +11 more
wiley   +1 more source

Diuretics in pediatrics

, 2023
Diuretics are frequently prescribed drugs and help managing several pathological conditions, including acute and chronic kidney disease, nephrotic syndrome, congestive heart failure, ascites, systemic and pulmonary hypertension.
Chiara Zollinger, Lava, SAG, Damien Schaffner, Sekarski, N., Di Bernardo, S., Stefano Di Bernardo, Nicole Sekarski, Schaffner, D., Sebastiano A. G. Lava, Chehade, H., Hassib Chehade, Zollinger, C.   +11 more
core   +1 more source

Deep Sequencing of FLT3‐ITD Enables Response Evaluation and Post‐Treatment Monitoring in Childhood AML: An Exploratory Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm, Bea Tornberg, Erik Delsing Malmberg, Henrik Hasle, Kristian Løvvik Juul‐Dam, Lars Palmqvist, Borhan R. Saeed, Giti Shah Barkhordar, Anastasia Soboli, Anna Staffas, Jonas Abrahamsson, Linda Fogelstrand   +11 more
wiley   +1 more source

Women in pediatrics: recommendations for the future

, 2011
Marianne Felice is a member of the Women Chairs of the Association of Medical School Pediatric Department Chairs.There are many reasons for addressing issues of family balance in the lives of pediatricians during training and practice, including concerns
Women Chairs of the Association of Medical School Pediatric Department Chairs, Felice, Marianne E.   +1 more
core   +1 more source

The Michigan Appropriateness Guide for Intravenous Catheters in Pediatrics: miniMAGIC

, 2020
Vascular access device decision-making for pediatric patients remains a complex, highly variable process. To date, evidence-based criteria to inform these choices do not exist. The objective of the Michigan Appropriateness Guide for Intravenous Catheters
Cooke, Marie, Kleidon, Tricia, Jacobs, Jeffrey P, Jaffray, Julie, Pitts, Stephanie, Stranz, Marc, Doellman, Darcy, Faustino, E Vincent S, Mahajan, Prashant, Ullman, Amanda J, Mahajan, Prashant V, Cooper, David S, Aiyagari, Ranjit, Wolf, Joshua, Rivard, Douglas C, Brown, Erin, Chopra, Vineet, Prentice, Elizabeth, Rickard, Claire M, Bernstein, Steven J, Morton, Kayce, Shaughnessy, Erin, Gore, Beth, McBride, Craig A   +23 more
core   +1 more source

A Quality Improvement Network for Interdisciplinary Training in Developmental Disabilities

, 2022
Children with developmental disabilities (DD), such as autism spectrum disorder (ASD), have complex health and developmental needs that require multiple service systems and interactions with various professionals across disciplines. The growing number of
Whitaker, Toni M., Chodron, Gail S., Rabidoux, Paula, Donahue, Michelle L., Smith, Jennifer D., Ford, Kristie, Nidey, Nichole, Klimova, Oksana, Macias, Michelle M., Czyzia, Jackie, Brosco, Jeffrey P., Lend Quality Improvement Network, James, Cristina   +12 more
core   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke, Christian Thomas, Michael C. Frühwald, Pascal D. Johann, Martin Hasselblatt   +4 more
wiley   +1 more source

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook, Veerain Gupta, Nicholas J. Clark, Vijay Rings, Lauren E. Corona, Douglass B. Clayton, Daniel J. Benedetti   +6 more
wiley   +1 more source